Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease.
Creatine kinase BB (CK-BB) isoenzyme was measured by radioimmunoassay in serum and in cerebrospinal fluid from 61 patients with various neurological disorders. Statistically significant elevations of CK-BB isoenzyme in the serum were observed in patients with acute cerebrovascular accidents and in those with seizures and a prolonged alteration in level of consciousness. Statistically significant elevations of CK-BB isoenzyme in the cerebrospinal fluid were also found in patients who had suffered acute cerebrovascular accidents. Some patients with central nervous system infections, acute demyelinating disease, certain drug overdoses, head trauma, and complex migraine also had elevations of serum and CSF CK-BB isoenzyme. In 2 patients with elevations of CK-BB isoenzyme, the elevations in serum occurred later than those detected in the cerebrospinal fluid. If CK-BB elevations determined by radioimmunoassay can be demonstrated to be quantitatively related to the extent of brain damage, then these determinations in conjunction with experimental animal models and newer radiological techniques should allow evaluation, in an objective and precise manner, of measures designed to decrease that damage.
D001925:Brain Damage, Chronic / Q000201:enzymology; D001927:Brain Diseases / Q000201:enzymology*; D003402:Creatine Kinase / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D006801:Humans; D007527:Isoenzymes / Q000032:analysis*; D011863:Radioimmunoassay / Q000379:methods*; D012640:Seizures / Q000201:enzymology
D007527:Isoenzymes; D003402:Creatine Kinase